You are here

Companies

13.06.2018

The percentage of foreign investors rose from 12% to 16% last year, according to the study by CataloniaBio & HealthTech and EY

07.06.2018

The initiative, led by Institut Guttmann, is part of the RIS3CAT community coordinated by Biocat and promoted through ACCIÓ

BioRegio Catalunya maig 2018
25.05.2018

Discoveries in neurodegenerative diseases, economic reports and advances in the 'pipeline' , in May's headlines

Chiesi partner Design Health Barcelona
28.05.2018

The pharmaceutical company is following the clinical immersion of students in the Pulmonology Department at Hospital Clinic

Biocat BioRegion abril 2018
24.04.2018

This month, researchers in the BioRegion have published articles in the highest impact science journals, while pharmaceutical and biotechnology companies have advanced their growth plans and drugs

BioRegio Març 2018
26.03.2018

New rounds of crowdfunding, patents, trade agreements and scientific publications round out the headlines for March in the BioRegion

Aceleradora enfermedades raras AMMIC RIS3CAT Biocat
05.03.2018

Acceleradora en Malalties Minoritàries de Catalunya (AMMIC) is part of the RIS3CAT community coordinated by Biocat. It is led by IUCT and other members include VHIR, Esteve, Aromics, BCN Peptides, Minoryx, Aniling and Qgenomics

BioRegio Catalunya febrer 2018
26.02.2018

Firm led by Jordi Carrera hits archetypal milestone for sector amidst effervescent month of February

Catalan Healthtech MWC
22.02.2018

The BioRegion of Catalonia has 110 healthtech companies and a new one is created every 20 days

start.smart.japan
19.02.2018

The Start.Smart.Japan program includes a week of training in Munich on the barriers to the Japanese market and a mission to BioJapan